We could not find any results for:
Make sure your spelling is correct or try broadening your search.
By Matt Grossman Aerie Pharmaceuticals Inc. has completed patient enrollment of a Phase 3 study in Japan testing its netarsudil ophthalmic solution as a treatment for glaucoma or ocular...
Parion Sciences Announces Exclusive Option Agreement for the Development and Commercialization of P-321 in Ophthalmology in Certain Asian Territories -- Parion has a plan for the first clinical...
Merck & Co. Inc. has reached a deal to sell some ophthalmology assets to Santen Pharmaceutical Co. Ltd. for distribution in Japan as well as markets in the Asia Pacific region and Europe...
Santen and TRACON Announce Agreement for the Development and Commercialization of TRC105 in Ophthalmology PR Newswire SAN DIEGO and OSAKA, Japan, March 4, 2014 SAN DIEGO and OSAKA, Japan, March...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.77 | -6.44891122278 | 11.94 | 12.79 | 10.32 | 2568 | 11.41005678 | DR |
4 | 0.54 | 5.07996237065 | 10.63 | 12.79 | 9.86 | 6285 | 10.77875567 | DR |
12 | -1.228 | -9.90482335861 | 12.398 | 13 | 9.86 | 4184 | 11.34730525 | DR |
26 | 0.87 | 8.44660194175 | 10.3 | 13 | 9.58 | 7745 | 11.50169666 | DR |
52 | 1.625 | 17.02462022 | 9.545 | 13 | 8.95 | 6145 | 11.00054264 | DR |
156 | -1.13 | -9.18699186992 | 12.3 | 13 | 6.2 | 29985 | 9.39135323 | DR |
260 | -7.89 | -41.3955928646 | 19.06 | 20.93 | 6.2 | 32691 | 12.08797609 | DR |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions